INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

For the key trials, our articles and recipes, read the Cancer Risk Reduction desk →

1,241 studies · page 38 of 52

2011 / Narrative review

Excess iron is implicated in increased cancer risk and regulating body iron stores may serve as a chemopreventive strategy.

This review discusses the balance of iron in human health, noting that iron deficiency causes anaemia while excessive iron increases cancer risk, likely via free radical generation. Iron overload-associated conditions, such as genetic haemochromatosis and endometriosis, increase cancer risks, and an epidemiological study noted that iron reduction via phlebotomy was associated with decreased cancer risks in a general population. In neurons, iron overload through ferroportin block may also be involved in Alzheimer's disease.

Shows an association, not proof of cause and effect.

Toyokuni S Free Radic Res, 2011. PMID 21615276

2011 / Narrative review

Cancer cachexia is recalcitrant to nutritional therapy, and treatment requires caution to avoid dangerous overfeeding syndrome.

This review examines cachexia, malnutrition, and refeeding syndrome. Cachexia linked with malignant diseases differs from starvation cachexia and is more recalcitrant to nutritional therapy. Although all cachexia responds to judicious nutritional support, cancer cachexia progresses autonomously and cannot be arrested or reversed by any known nutrition, hormonal, or pharmacologic therapy. Treatment must proceed cautiously to avoid overfeeding syndrome, which can cause serious complications or death.

Palesty JA, Dudrick SJ Surg Clin North Am, 2011. PMID 21621702

2011 / Commentary / narrative perspective

Public health communication must connect statistics to human stories to motivate lifestyle changes against chronic disease.

The author notes that basic lifestyle changes could eliminate 80% of all heart disease and strokes, 90% of all diabetes, and 60% of all cancers. However, efforts have failed to motivate the public to adopt these changes or policy makers to make healthy choices the easiest option. Dr. Katz suggests this failure stems from overemphasizing statistics and underemphasizing passion, urging advocates to connect statistics to human stories.

Katz DL Am J Health Promot, 2011. PMID 21721959

2011 / Modeling / literature-based estimation study

A modeling study estimated that doubling serum 25(OH)D levels could reduce all-cause mortality rates by 7.6% to 17.3% across global regions.

This study estimated the reduction in mortality rates across six geopolitical regions assuming serum 25(OH)D levels increase from 54 to 110 nmol/l, based on published literature on UVB, vitamin D, and disease risks. Increasing serum 25(OH)D was estimated to reduce mortality from vitamin D-sensitive diseases by 20%. Estimated reductions in all-cause mortality ranged from 7.6% for African females to 17.3% for European females, averaging 0.6% lower for males than females. Estimated life expectancy increased by 2 years across all six regions.

Grant WB Eur J Clin Nutr, 2011. PMID 21731036

2011 / Narrative review / commentary

A review argues that the minimum desirable serum 25-hydroxyvitamin D level should exceed 75 nmol/L rather than the IOM recommendation of 50 nmol/L.

This article examines the Institute of Medicine (IOM) recommendation to maintain serum 25-hydroxyvitamin D (25(OH)D) at or above 50 nmol/L. The author argues that 25(OH)D should preferably exceed 75 nmol/L (30 ng/mL) based on re-evaluation of bone density and osteomalacia data, evolutionary biology, clinical trials, and epidemiological links to fewer falls, better tooth attachment, less colorectal cancer, and improved depression. The author attributes reported risks of prostate cancer, pancreatic cancer, or mortality at higher latitudes to dynamic seasonal fluctuations in 25(OH)D.

Vieth R Best Pract Res Clin Endocrinol Metab, 2011. PMID 21872808

2011 / Narrative review

A review explores the controversy surrounding the health hazards and perceived benefits of artificial sweeteners.

This review aims to examine the health controversy over the perceived benefits of sugar substitutes. The authors note that while artificial sweeteners provide sweetness with less food energy, animal studies have demonstrated adverse effects such as weight gain, brain tumors, bladder cancer, and other hazards. In humans, certain health-related side effects, including carcinogenicity, have also been reported, leaving scientists divided on their safety.

Tandel KR J Pharmacol Pharmacother, 2011. PMID 22025850

2011 / Review

Prospective studies link higher whole grain intake to lower BMI, but clinical trials do not confirm greater weight loss than refined cereal diets.

This viewpoint evaluated literature examining whole grain consumption and body weight regulation, potential mechanisms, and discrepancies between epidemiological studies and clinical trials. All prospective epidemiological studies demonstrated that higher intake of whole grains was associated with lower BMI and body weight gain. However, results from a few clinical trials did not confirm that a whole grain low-calorie diet was more effective in reducing body weight than a refined cereal diet, which may have been affected by small sample sizes or short intervention durations.

Shows an association, not proof of cause and effect.

Giacco R, Della Pepa G, Luongo D, et al. Nutr Metab Cardiovasc Dis, 2011. PMID 22036468

2011 / Systematic review

Observational evidence linked low-fat, high-fiber diets and physical activity to better prognostic outcomes in breast, colorectal, and prostate cancer.

A review of 43 records from the Cochrane Library and PubMed examined diet and physical activity in breast, colorectal, and prostate cancer survivorship. Observational studies suggested that a low-fat, high-fibre diet might be protective against recurrence and progression, but randomized controlled trials were lacking. Stronger evidence supported physical activity, showing a dose response for better outcomes. Synthesized with World Cancer Research Fund trial data, findings suggest the mechanism of benefit relates to body weight, an excess of which is a modifiable risk factor.

Shows an association, not proof of cause and effect.

Davies NJ, Batehup L, Thomas R Br J Cancer, 2011. PMID 22048034

2011 / Review of observational studies

A review of 62 studies proposed a carotenoid health index linking higher plasma carotenoids to lower risks of mortality, metabolic syndrome, and cancer.

Sixty-two studies of plasma carotenoids and health outcomes, primarily prospective cohort or population-based case-control designs, were analyzed to develop a carotenoid health index. Cutoff points across the 10th to 90th percentiles were established at 1.11, 1.47, 1.89, 2.52, and 3.07 µM. A low threshold effect appeared for all-cause mortality with protection above every cutoff except the lowest, whereas metabolic syndrome and cancer showed significant positive outcomes only above higher cutoffs. A proposed carotenoid health index categorized risk from very high (<1 µM) to very low (>4 µM), with over 95% of the US population falling into the moderate or high risk categories.

Shows an association, not proof of cause and effect.

Donaldson MS Nutrients, 2011. PMID 22292108

2011 / Narrative review of pharmacokinetic and pharmacology studies

Oral vitamin C plasma levels are tightly controlled below 250 μmol/L, while intravenous infusion bypasses controls to achieve levels of 25-30 mmol/L.

Pharmacokinetic studies show that oral vitamin C intake results in tightly controlled plasma concentrations that do not exceed 100 μmol/L from foods, and remain <250 μmol/L even with maximally tolerated supplementation doses. In contrast, intravenous infusion bypasses this tight control to safely achieve pharmacologic concentrations of 25-30 mmol/L. These pharmacologic concentrations can act as a pro-drug for hydrogen peroxide formation, eliciting cytotoxicity against cancer cells and slowing tumor growth in murine models.

Levine M, Padayatty SJ, Espey MG Adv Nutr, 2011. PMID 22332036

2011 / Narrative review

A review notes turmeric consumption may potentially help prevent chronic diseases such as cancer, though epidemiologic data remain limited.

This review provides an overview of global turmeric consumption, cancer rates across regions, and potential biochemical mechanisms of action. The authors note that curcumin, the primary therapeutic phytochemical in turmeric, has been investigated for chronic diseases including diabetes, Alzheimer's, and cancer. However, there is currently little epidemiologic information on the specific effects of dietary turmeric consumption.

Shows an association, not proof of cause and effect.

Hutchins-Wolfbrandt A, Mistry AM Asian Pac J Cancer Prev, 2011. PMID 22471448

2011 / Narrative review

A review reports that Withania somnifera (Ashwagandha) exhibits anti-stress, neuroprotective, anti-inflammatory, and anti-tumor properties across various models.

This review summarizes scientific findings on Withania somnifera (Ashwagandha). In experimental models, it increased stamina in swimming tests, prevented stress-related adrenal changes, protected against stress-induced gastric ulcers, and exhibited anti-tumor effects in animal and cell models. It demonstrated cognition-promoting effects in children with memory deficits and elderly individuals, was reported useful in neurodegenerative conditions and arthritis, and exhibited anxiolytic and GABA-mimetic actions. The authors note that large-scale studies are needed to prove clinical efficacy in stress-related disorders, neuronal disorders, and cancers.

Singh N, Bhalla M, de Jager P, et al. Afr J Tradit Complement Altern Med, 2011. PMID 22754076

2010 / Narrative review and hypothesis

A review notes alcohol drinkers have more sunburns and higher skin cancer prevalence, proposing alcohol metabolites combined with UV radiation enhance damage.

Current literature indicates that alcohol drinkers experience increased episodes of sunburn and a higher prevalence of skin cancer. The authors hypothesize that combining alcohol consumption with UV radiation potentiates skin carcinogenic effects because alcohol byproducts or metabolites act as photosensitizers, enhancing cellular damage. While existing literature explores this mutual effect, no studies have definitively ascribed the reasons for the elevated skin cancer prevalence among alcohol drinkers.

Shows an association, not proof of cause and effect.

Saladi RN, Nektalova T, Fox JL Clin Exp Dermatol, 2010. PMID 19778305

2010 / Benefit-risk review of RCTs and prospective cohorts

Review suggests serum 25(OH)D levels of 75 to 110 nmol/l provide optimal benefits for falls, fractures, and other endpoints without increasing health risks.

This study evaluated the benefits and risks of higher vitamin D doses and achieved 25(OH)D levels using double-blind RCTs and prospective cohort data. Based on RCTs for falls (n = 2,426) and non-vertebral fractures (n = 42,279), optimal benefits were observed at 700 to 1,000 IU/day or mean 25(OH)D between 75 and 110 nmol/l. Prospective cohort data on cardiovascular health and colorectal cancer suggested increased benefits with the highest categories evaluated (median 75 to 110 nmol/l). In 25 RCTs, oral vitamin D up to 100,000 IU/day or achieved 25(OH)D up to 643 nmol/l was not related to mean serum calcium, and levels of 75 to 110 nmol/l were reached in most RCTs with 1,800 to 4,000 IU/day without risk.

Bischoff-Ferrari HA, Shao A, Dawson-Hughes B, et al. Osteoporos Int, 2010. PMID 19957164

2010 / Narrative review

Male reproductive function is vulnerable to occupational toxicants and low-level biopersistent dietary pollutants.

This review examines environmental hazards linked to male reproductive disorders such as sexual dysfunction, infertility, cryptorchidism, hypospadias, and testicular cancer. Occupational exposures to physical factors, solvents, pesticides, and heavy metals represent the best-documented risk factors for impaired male reproduction. Emerging data also indicate that low-level exposure to biopersistent pollutants in the diet may pose risks globally, while the risks from compounds like phthalates and bisphenol A remain to be established.

Shows an association, not proof of cause and effect.

Bonde JP Asian J Androl, 2010. PMID 19966832

2010 / Systematic literature review (1995-2006)

A review of 1995-2006 evidence found no support for a single quantitative sugar guideline covering all health outcomes.

This review analyzed published studies from 1995 to 2006 to evaluate whether sugar consumption harms health. High-quality obesity studies did not find a positive association between body mass index and sugar intake, though some sweetened beverage studies raised concerns but had important methodological limitations. Long-term studies on metabolic syndrome reported no adverse effects even at intakes of 40-50% energy, and diet adequacy was achieved across intakes of 6 to 20% energy depending on age. Colorectal cancer associations appeared confounded by energy intake and glycemic load, no credible link was found for mental health conditions, and caries risk depended on multiple factors beyond sugar amount alone.

Ruxton CH, Gardner EJ, McNulty HM Crit Rev Food Sci Nutr, 2010. PMID 20047137

2010 / Narrative review / hypothesis

Authors propose that high dietary phosphate from dairy products may explain the linked risk of prostate cancer rather than calcium.

Epidemiologic correlations have indicated an increased risk of prostate cancer with long-term, high intake of dairy products in male U.S. physicians and males in Sweden. Although this relation has been mechanistically associated with calcium, the authors propose that high dietary phosphate in dairy affects much larger fluctuation in serum phosphate. Therefore, dietary phosphate may be a more likely source of prostate cancer risk from high dairy intake.

Shows an association, not proof of cause and effect.

Newmark HL, Heaney RP Nutr Cancer, 2010. PMID 20358466

2010 / Narrative review

Reviews show organic foods contain higher levels of certain nutrients, lower pesticide residues, and may reduce allergic dermatitis from organic dairy.

This review evaluated the nutritional and safety differences between organic and non-organic foods. Reviews of multiple studies indicate that organic varieties provide significantly greater levels of vitamin C, iron, magnesium, and phosphorus, while containing significantly lower levels of nitrates and pesticide residues. Organic foods also typically have higher levels of antioxidant phytochemicals like anthocyanins, flavonoids, and carotenoids (except in wheat, oats, and wine). While in vitro studies show greater antioxidant and anti-cancer activity, in vivo studies in humans have not demonstrated additional antioxidant benefits, though clear benefits for allergic dermatitis have been demonstrated with organic dairy.

Crinnion WJ Altern Med Rev, 2010. PMID 20359265

2010 / Narrative review

Reviews by the NCI and medical societies found no evidence supporting the usefulness of the Gerson regimen as an alternative cancer therapy.

The Gerson regimen is promoted as an alternative cancer treatment using raw fruit and vegetable juices, salt elimination, various supplements, and coffee enemas. Scientific research has not substantiated the underlying theories of the regimen. Despite claims of 70% to 90% recovery rates, case reviews by the National Cancer Institute (NCI) and New York County Medical Society found no evidence of its usefulness. Furthermore, an NCI-sponsored study of the similar Gonzalez therapy showed patients with inoperable pancreatic adenocarcinoma on standard gemcitabine chemotherapy survived three times longer and had better quality of life than those on the enzyme and diet regimen.

Cassileth B Oncology (Williston Park), 2010. PMID 20361473

2010 / Narrative review

Dietary restriction and reduced nutrient-sensing pathway activity can extend life span and protect against age-related diseases across species.

This review examines evidence showing that dietary restriction or reduced nutrient-sensing pathway activity extends life span across species such as yeast and rodents. In rodents, these interventions can lower the incidence of tumors and neurodegeneration, while in rhesus monkeys dietary restriction increases life span and protects against diabetes, cancer, and cardiovascular disease. In humans, dietary restriction causes changes that protect against age-related pathologies, and natural genetic variants in nutrient-sensing pathways are associated with increased life span. The authors discuss potential applications for disease prevention and healthy aging alongside the challenge of possible negative side effects.

Fontana L, Partridge L, Longo VD Science, 2010. PMID 20395504

2010 / Review / nested case-control study overview

In EPIC Norfolk, enterolignan intake was inversely linked to colorectal cancer in women, with no significant link between phytoestrogen intake and breast cancer.

This article reviews phytoestrogen consumption and cancer risk, focusing on findings from a nested case-control study in EPIC Norfolk. Phytoestrogen intake was not significantly associated with breast cancer risk. Colorectal cancer risk was inversely associated with enterolignan intake in women but not in men. Prostate cancer risk was positively associated with enterolignan intake, but this association became non-significant after adjusting for dairy intake, suggesting enterolignans may act as a surrogate marker for dairy or calcium intake.

Shows an association, not proof of cause and effect.

Ward HA, Kuhnle GG Arch Biochem Biophys, 2010. PMID 20494649

2010 / Narrative review

A review details evidence linking circadian disruption, reduced sleep, shift work, and light at night to increased adiposity and obesity.

This review evaluates developments in chronobiology and obesity, examining how molecular clocks coordinate metabolism, circadian disruption (CD) and its causes, and epidemiological evidence of obesity as a chronobiological illness. Sleep duration has declined by 1.5 hours over the past century alongside an important rise in obesity, while shift work, sleep deprivation, and exposure to bright light at night increase adiposity prevalence. Animal models demonstrate that Clock gene disruption renders mice prone to obesity and metabolic syndrome. The review also explores energy balance, fat intake from a circadian perspective, and chronobiological approaches to obesity treatment.

Shows an association, not proof of cause and effect.

Garaulet M, Ordovás JM, Madrid JA Int J Obes (Lond), 2010. PMID 20567242

2010 / Narrative review

A review notes frequent discrepancies between observational studies and clinical trials regarding dietary factors and cancer risk.

This review summarizes developments in nutritional epidemiology and cancer, presenting evidence on dietary fat, meat, fiber, antioxidant nutrients, and calcium from large cohort studies and randomized clinical trials (RCTs). A prominent theme is the lack of concordance between results from RCTs and observational studies. Discrepancies may arise from differences in study populations, dose and timing of exposure, intervention adherence, length of follow-up, and primary endpoints. The authors suggest that null RCT findings do not necessarily rule out chemopreventive effects and that potential dietary benefits likely stem from combinations of food constituents rather than isolated single components.

Gibson TM, Ferrucci LM, Tangrea JA, et al. Semin Oncol, 2010. PMID 20709210

2010 / Narrative review

After 33 years and at least 1,591 patients, it remains unknown whether vitamin C has clinically significant antitumor activity.

This review evaluates 33 years of clinical trials involving at least 1,591 cancer patients treated with vitamin C. A 1976 study reporting that 100 terminal cancer patients given intravenous and oral vitamin C lived four times longer than 1,000 controls was strongly criticized for major control group imbalances that artificially extended survival. Subsequent trials, including three double-blind placebo-controlled randomized trials of oral vitamin C at the Mayo Clinic, were negative, and a phase I-II trial of intravenous vitamin C found zero responses in 24 patients. The authors conclude it is still unknown whether vitamin C has any clinically significant antitumor activity, which cancer types might be susceptible, or what dose might produce a therapeutic response.

Cabanillas F P R Health Sci J, 2010. PMID 20799507